+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Proton magnetic resonance spectroscopy and cognitive impairment in patients with ischemic white matter lesions



Proton magnetic resonance spectroscopy and cognitive impairment in patients with ischemic white matter lesions



Journal of Research in Medical Sciences 18(12): 1061-1066



The purpose of this study is to investigate the relationship between the cognitive impairment and NAA/Cr and Cho/Cr ratios in the proton magnetic resonance spectroscopy ((1)HMRS), and to assess the importance of (1)HMRS in the early diagnosis of cognitive impairment in patients with ischemic white matter lesions (WMLs). A total of 45 patients (23 males and 22 females) with the ischemic WML were divided into mild WML group (n = 15), moderate WML group (n = 15), and severe WML group (n = 15). A total of 15 healthy controls (8 males and 7 females) with no WML on magnetic resonance imaging were included. (1)HMRS focusing on the frontal lobe white matter around the anterior horn of the lateral ventricle and Montreal Cognitive Assessment (MoCA) were conducted. Patients with more severe WML had lower MoCA scores. The NAA/Cr ratio in (1)HMRS was reduced in all the patients and was strongly correlated with the total MoCA scores (r = 0.845, P < 0.001). The Cho/Cr ratio in (1)HMRS was increased in mild and moderate patients, was negatively correlated with the total MoCA scores (r = 0.907, P < 0.001). The Cho/Cr ratio was reduced in the severe patients and was positively correlated with the total MoCA scores (r = 0.937, P < 0.001). In addition, NAA/Cr and Cho/Cr ratios in (1)HMRS were changed in patients with the mild WML whose total MoCA scores were similar to the controls. Our results suggest that NAA/Cr and Cho/Cr ratios in (1)HMRS are useful indicators for early diagnosis of ischemic WML and cognitive impairment in patients with ischemic WML.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 055260117

Download citation: RISBibTeXText

PMID: 24523797


Related references

Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals. Archives of Neurology 48(4): 417-420, 1991

Proton magnetic resonance spectroscopy and white matter hyperintensities on magnetic resonance imaging in patients with Alzheimer's disease. Annals of the New York Academy of Sciences 977: 423-429, 2002

The Role of Disturbed Small-World Networks in Patients with White Matter Lesions and Cognitive Impairment Revealed by Resting State Function Magnetic Resonance Images (rs-fMRI). Medical Science Monitor 25: 341-356, 2019

Proton magnetic resonance spectroscopy and gadolinium-DTPA perfusion imaging of asymptomatic MRI white matter lesions. Magnetic Resonance in Medicine 33(1): 61-68, 1995

Hydrogen Proton Magnetic Resonance Spectroscopy in Multidomain Amnestic Mild Cognitive Impairment and Vascular Cognitive Impairment Without Dementia. American Journal of Alzheimer's Disease and Other Dementias 31(5): 422-429, 2017

Proton magnetic resonance spectroscopy of the hippocampus in patients with mild cognitive impairment: a pilot study. Journal of Computer Assisted Tomography 31(5): 666-670, 2007

Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging. Radiologia 48(5): 301-307, 2006

Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy. Journal of Clinical Psychiatry 64(3): 235-242, 2003

Brain metabolism assessed via proton magnetic resonance spectroscopy in patients with amnestic or vascular mild cognitive impairment. Clinical Neurology and Neurosurgery 130(): 80-85, 2015

Intracranial deep white matter lesions (DWLs) are associated with chronic kidney disease (CKD) and cognitive impairment: a 5-year follow-up magnetic resonance imaging (MRI) study. Archives of Gerontology and Geriatrics 56(1): 55-60, 2013

Proton magnetic resonance spectroscopy of human brain: applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities. Magnetic Resonance in Medicine 26(2): 313-327, 1992

Effects of dioscorea modified pill on cognitive impairment of patients with VCIND: an preliminary study of proton magnetic resonance spectroscopy. Zhonghua Yi Xue Za Zhi 94(39): 3075-3078, 2015

Proton magnetic resonance spectroscopy in white matter of patients with symptomatic lacunar infarcts and vascular leukoencephalopathy. Neurology 56(8 Supplement 3): A261, April 24, 2001

White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings. European Journal of Pediatrics 152(12): 1012-1020, 1993

Proton magnetic resonance spectroscopy of periventricular white matter and hippocampus in obstructive sleep apnea patients. Polish Journal of Radiology 78(4): 7-14, 2014